NCT06452498: Preeclampsia Intervention Netherlands
- State
- Under way
- Phase
- Phase 3
- People
- 180 planned
- Started
- 19 Sep 2025
- Primary completion
- 19 Mar 2029
- Arms
- Metformin
- Results
- None posted
- 11 Jun 2024: Trial registered
- 19 Sep 2025: Trial started
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.
Kind of treatment: Drug.
Also known as Apophage, Benofomin, Diabefagos, Diabex, Extended Release Metformin Hydrochloride, Fortamet, Glucaminol, Glucophage, Glucophage xr, Glucovance component metformin hydrochloride, Glumetza, Invokamet component metformin hydrochloride, Janumet component metformin hydrochloride, Kazano component metformin hydrochloride, Metformin XR, Metformin hydrochloride (HCl) 500mg tablet, Neodipa, Qternmet component metformin hydrochloride, Qternmet xr component metformin hydrochloride, Riomet, Riomet er, Segluromet component metformin hydrochloride, Siamformet, Trijardy xr component metformin hydrochloride, Walaphage, Xigduo component metformin hydrochloride, Zituvimet component metformin hydrochloride.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.